Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.ajg.2020.04.019

http://scihub22266oqcxt.onion/10.1016/j.ajg.2020.04.019
suck pdf from google scholar
32439237!7214343!32439237
unlimited free pdf from europmc32439237    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32439237      Arab+J+Gastroenterol 2020 ; 21 (2): 69-75
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Liver transplantation in the era of COVID-19 #MMPMID32439237
  • El Kassas M; Alboraie M; Al Balakosy A; Abdeen N; Afify S; Abdalgaber M; Sherief AF; Madkour A; Abdellah Ahmed M; Eltabbakh M; Salaheldin M; Wifi MN
  • Arab J Gastroenterol 2020[Jun]; 21 (2): 69-75 PMID32439237show ga
  • Liver transplantation is considered the ultimate solution for patients with end-stage chronic liver disease or acute liver failure. Patients with liver transplant need special care starting from preoperative preparation, surgical intervention ending with postoperative care. Transplanted patients have to receive immunosuppressive therapy to prevent rejection. Such a state of immune suppression could predispose to different types of infections in liver transplant recipients. Currently, the world is suffering a pandemic caused by a new strain of the coronavirus family called COVID-19. Certain infection control precautions are needed to protect immunocompromised and vulnerable patients, including liver transplant candidates and recipients from acquiring COVID-19 infection. Restricting non-transplant elective surgical procedures, managing transplant patients in separate outpatient clinics, and in-patient wards can prevent transmission of infection both to patients and healthcare workers. Telemedicine can help in the triage of patients to screen for symptoms of COVID-19 before their regular appointment. Management of immunosuppressive therapy and drug-drug interactions in liver transplant recipients infected with COVID-19 should be cautiously practiced to prevent rejection and effectively treat the underlying infection. In this report, we are trying to summarize available evidence about different aspects of the management of liver transplant candidates and recipients in the era of COVID-19.
  • |*Coronavirus Infections/epidemiology/prevention & control/transmission[MESH]
  • |*End Stage Liver Disease/epidemiology/surgery[MESH]
  • |*Liver Failure, Acute/epidemiology/surgery[MESH]
  • |*Pandemics/prevention & control[MESH]
  • |*Pneumonia, Viral/epidemiology/prevention & control/transmission[MESH]
  • |Betacoronavirus/isolation & purification[MESH]
  • |COVID-19[MESH]
  • |Comorbidity[MESH]
  • |Disease Transmission, Infectious/*prevention & control[MESH]
  • |Humans[MESH]
  • |Infection Control/*methods[MESH]
  • |Liver Transplantation/*methods[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box